RUNX1 and CCL3 in Diabetes Mellitus-Related Coronary Artery Disease: A Bioinformatics Analysis

Yi Zhong1,2, Guoyong Du1,2, Jie Liu1,2

  • 1Department of Cardiology, The Fifth Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530022, People's Republic of China.

Insights

Cardiovascular complications in diabetes mellitus are linked to viral infection pathways. CCL3 may be a key regulator, and RUNX1 a key transcription factor in diabetes mellitus-associated coronary artery disease.

Area of Science:

  • Genomics
  • Bioinformatics
  • Cardiovascular Research

Background:

  • Cardiovascular complications are a leading cause of death in diabetes mellitus patients.
  • The underlying mechanisms of these complications remain largely unknown.

Purpose of the Study:

  • To investigate the molecular mechanisms of diabetes mellitus-associated coronary artery disease (DMCAD).
  • To identify key regulators and transcription factors involved in DMCAD progression.

Main Methods:

  • Weighted gene correlation network analysis (WGCNA) on gene expression profiles.
  • Gene Ontology (GO) and Kyoto Gene and Genome Encyclopedia (KEGG) pathway enrichment analysis.
  • Gene set enrichment analysis (GSEA), ClueGo, and regulatory network construction.

Main Results:

  • Three gene modules associated with DMCAD progression were identified.
  • Module genes are involved in interferon, viral infection, viral myocarditis, and chemokine signaling pathways.
  • RUNX1 was identified as a potential transcription factor, and CCL3 as a key regulator in DMCAD.

Conclusions:

  • Bioinformatic analysis suggests CCL3 is a key regulator in DMCAD.
  • RUNX1 is identified as a key transcription factor in the development of DMCAD.
Abstract